AE Wealth Management’s Kyntra Bio KYNB Stock Holding History

AE Wealth Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-431	Closed	-$374K	–	1283
2020 Q1	$374K	Buy	+431	New	+$428K	0.01%	790

Other funds holding KYNB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

AE Wealth Management's KYNB Position: Q2 2020 in Review

AE Wealth Management sold out of Kyntra Bio (KYNB) in Q2 2020, closing a stake of 431 shares — an estimated $374K sold.

AE Wealth Management first reported a position in KYNB in Q1 2020 and held it in 1 quarter. The position peaked at $374K in Q1 2020. 194 funds tracked by Wall St. Rank hold KYNB as of Q2 2020.

AE Wealth Management reported no remaining Kyntra Bio position as of Q2 2020 after selling out during the quarter.
AE Wealth Management sold 431 Kyntra Bio shares in Q2 2020, an estimated $374K.
AE Wealth Management first reported a position in Kyntra Bio in Q1 2020 and held it in 1 quarter.
AE Wealth Management's Kyntra Bio position peaked at $374K in Q1 2020.
194 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2020.

Based on AE Wealth Management's 13F filing for Q2 2020, filed 5 Aug 2020.